Tuning Reactivity of Platinum(II) Complexes

17 R. A. Henderson, The Mechanism of Reactions oat Transition Metal Sites, Oxford
University Press, Oxford, 1993, p. 1.
18 A. Sigel and H. Sigel, Metal ions in biological systems. Marcel Dekker Inc, New
York, 1996, p 393.
19 M.L. Tobe and J. Burgess, Inorganic reaction mechanisms. Addison Wesley
Longman Ltd., Essex, 1999, pp 30–43, 70–112.
20 J. D. Atwood, Inorganic and Organometallic reaction mechanisms, 2 nd Ed., Wiley-
VCH Inc, New York, 1997, pp 43–61.
21 B. Rosenberg, L. Van Camp, E.B. Grimley, et al. J. Biol. Chem., 1967, 25, 1347–
1352.
22 (a) S. Hochreuther, S. T. Nandibewoor, R. Puchta, and R. van Eldik, Dalton Trans.,
2012, 41, 512; (b) S. Hochreuther, R. Puchta, and R. van Eldik, Inorg. Chem., 2012,
51, 3025; (c) S. Hochreuther, R. Puchta, and R. van Eldik, Inorg. Chem., 2012, 50,
12747.
23 J. Reedijk, In: How can platinum antitumor compounds reach the cellular DNA?
226th ACS National Meeting, New York, NY, United states, September 7-11, 2003;
New York, NY, United states, 2003.
24 (a) T. Soldatovic´, S. Jovanovic´, Z. D. Bugarcˇic´ and R. van Eldik, Dalton Trans.,
2012, 41, 876; (b) S.J. Lippard, In: Progress in Inorganic Chemistry, Bioinorganic
Chemistry, Vol. 48; John Wiley and Sons: Sydney,1995.
25 B. E. Lippert, Cisplatin: Chemistry and Biochemistry of a Leading anticancer Drug,
Wiley-VCH: Zürich, 1999; (b) X. J. Lin, T. Okudua, A. Holzer and S. B. Howell, Mol.
Pharmacol., 2002, 62, 1154; (c) K. S. Lovejoy, and S. J. Lippard, Dalton Trans.,
2009, 48, 1065.
26 C. A. Puckett, R. J. Ernst and J. K. Barton, Dalton Trans. 2010, 39, 1159–1170.
27 C. W. Schwietert and J. P. McCue, Coord. Chem. Rev., 1990, 184, 67.
28 A. L. Harris, X. Yang, A. Hegmans, L. Povirk, J. J. Ryan, L. Kelland and N. P. Farrell,
Inorg. Chem., 2005, 44, 9598.
29 (a) J. Reedijk, Chem. Commun., 1996, 801; (b) G. McGowan, S. Parsons and P. J.
Sadler, Inorg. Chem., 2005, 44, 7459.
30 S. E. Miller and D. A. House, Inorg. Chim. Acta, 1989, 166, 189.
21